Join the Oncology Voice Network. Join for Free
Master Communication Skills to Improve Business Relations
MSL communication skills Medical Affairs engagement KOL and HCP engagement digital tools in MSL communication trends in Medical Affairs

Master Communication Skills to Improve Business Relations


Share This Article


Summary

In this episode, MSL Talk hosts its first live broadcast with panelists Ruth Phillips, Michael Kahn, John Caskey, and Brian Bischel. The conversation centers on enhancing communication skills within MSL teams, tackling deficiencies, and engaging effectively with KOLs and HCPs. The panel discusses internal communication challenges, the misalignment of goals in Medical Affairs, and strategies to combat remote communication fatigue. They explore the impact of digital tools, including social media and AI, on MSL engagement. Audience polls provide insights into stakeholder challenges, and panelists offer solutions for unresponsive stakeholders. The episode concludes with future trends in MSL communication.

The MSL Talk Podcast and Momentum Events teamed up for a first ever LIVE broadcast at the Medical Affairs Xcellence Summit, Philadelphia, PA. The live panel discussion was moderated by MSL Talk Host Tom Caravela and the topic was "Master Communication Skills to Improve Business Relations, and MAXimize Internal and External Engagement". Panelists included Bryan Bishel, Ruth Phillips and Michael Kahn.

The panel discussed:

👉 Training practices, techniques and trends that have been effective in developing communication skills for cross functional influence
👉 What skills need to be developed better for new or even seasoned professionals
👉 How professionals can position themselves better when contacting KOLs, DOLs and HCPs in general, gain better insights and create lasting relationships
👉 How an IIT program helps to drastically improve KOL engagement
👉 What engagement will look like in the next 5 years and what new trends might emerge.

Click for Source
MSL communication skills, Medical Affairs engagement, KOL and HCP engagement, digital tools in MSL, communication trends in Medical Affairs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Podcast
MSL Career Options: The transition from Field Medical to Medical Director
Partner Avatar MSL Talk: Tom Caravela, Josh Corriveau

MSL Career Options: The transition from Field Medical to Medical Director

Article
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
OVN Avatar Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Article
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
OVN Avatar Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Article
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies
OVN Avatar Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies

Explore OVN